Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Sep 28;6(3):237-239.
doi: 10.1080/20961790.2021.1938802. eCollection 2021.

Paroxetine overdose during pregnancy

Selin Acar  1   2 , Hilal Erol  2 , Elif Keskin Arslan  2 , Nusret Uysal  1   2 , Barış Karadaş  1   2 , Tijen Kaya Temiz  1   2 , Yusuf Cem Kaplan  2
Affiliations
Case Reports

Paroxetine overdose during pregnancy

Selin Acar et al. Forensic Sci Res. .

Abstract

Paroxetine is a selective serotonin reuptake inhibitor (SSRI) used in the treatment of depression and anxiety disorders. In some epidemiological studies, slightly increased risks of major malformations and cardiac malformations have been reported following paroxetine exposure in the first trimester of pregnancy. However, such findings have been inconsistent. There is only one report of any overdose of an SSRI during pregnancy, and that involved escitalopram. The aim of this case report was to describe the impact of a paroxetine overdose in the first trimester of pregnancy on the health of the foetus. A 21-year-old mother of one child who was pregnant with a second child was prescribed 20 mg/day paroxetine hydrochloride for the treatment of anxiety/depression. The patient ingested 15 or 16 20-mg tablets of paroxetine hydrochloride (300-320 mg) during the 5th week of pregnancy as a suicide attempt. Within 15 min of ingestion, she was admitted to hospital and treated for intoxication. No evidence of maternal SSRI intoxication was observed after treatment. The patient consulted our teratology information service for further risk assessment regarding possible major congenital malformations following the paroxetine overdose. We were unable to find previous reports of paroxetine overdose during pregnancy in the literature. The timely administration of the overdose treatment and the lack of maternal intoxication symptoms were considered positive for the foetal well-being, and the patient was referred for perinatology and psychiatry follow-ups. A healthy, 3 500-g male infant was born at 38 weeks' gestation, and his development at the age of 2 years was normal. This is the first reported case of paroxetine overdose during pregnancy. Comprehensive studies are needed to evaluate pregnancy outcomes after SSRI overdose.Key PointsThere are no reported data on paroxetine overdose during pregnancy.The aim of this case report was to describe the impact of a maternal paroxetine overdose in the first trimester of pregnancy on the health of the foetus. No evidence of maternal SSRI intoxication was observed.No congenital malformations or developmental disorders were observed in the child at 2 years of age.Comprehensive studies are needed to evaluate pregnancy outcomes following SSRI overdose.

Keywords: Forensic sciences; case report; forensic toxicology; overdose; paroxetine; teratogenicity.

PubMed Disclaimer

Conflict of interest statement

No conflicts of interest are declared by any of the authors.

References

    1. Bérard A, Iessa N, Chaabane S, et al. . The risk of major cardiac malformations associated with paro­xetine use during the first trimester of pregnancy: a systematic review and meta-analysis. Br J Clin Pharmacol. 2016;81:589–604. - PMC - PubMed
    1. Bérard A, Ramos E, Rey E, et al. . First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage. Birth Defects Res B Dev Reprod Toxicol. 2007;80:18–27. - PubMed
    1. Roca A, Garcia-Esteve L, Imaz ML, et al. . Obstetrical and neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitors: the relevance of dose. J Affect Disord. 2011;135:208–215. - PubMed
    1. Tixier H, Feyeux C, Girod S, et al. . Acute voluntary intoxication with selective serotonin reuptake inhibi­tors during the third trimester of pregnancy: therapeutic management of mother and fetus. Am J Obstet Gynecol. 2008;199:e9–e12. - PubMed
    1. Yates LM, Stephens S.. Poisonings and toxins. In: Schaefer C, Peters P, Miller RK, editors. Drugs during pregnancy and lactation: treatment options and risk assessment. 3rd ed. Amsterdam (The Netherlands): Academic Press; 2015. p. 575–597.

Publication types